Targeted next-generation sequencing for the genetic diagnosis of dysferlinopathy

Ha Young Shin, Hoon Jang, Joo Hyung Han, Hyung Jun Park, Jung Hwan Lee, So Won Kim, Seung Min Kim, Young Eun Park, Dae Seong Kim, Duhee Bang, Min Goo Lee, Ji Hyun Lee, Youngchul Choi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Dysferlinopathy comprises a group of autosomal recessive muscular dystrophies caused by mutations in the DYSF gene. Due to the large size of the gene and its lack of mutational hot spots, analysis of the DYSF gene is time-consuming and laborious using conventional sequencing methods. By next-generation sequencing (NGS), DYSF gene analysis has previously been validated through its incorporation in multi-gene panels or exome analyses. However, individual validation of NGS approaches for DYSF gene has not been performed. Here, we established and validated a hybridization capture-based target-enrichment followed by next-generation sequencing to detect mutations in patients with dysferlinopathy. With this approach, mean depth of coverage was approximately 450 fold and almost all (99.3%) of the targeted region had sequence coverage greater than 20 fold. When this approach was tested on samples from patients with known DYSF mutations, all known mutations were correctly retrieved. Using this method on 32 consecutive patient samples with dysferlinopathy, at least two pathogenic variants were detected in 28 (87.5%) samples and at least one pathogenic variant was identified in all samples. Our results suggested that the NGS-based screening method could facilitate efficient and accurate genetic diagnosis of dysferlinopathy.

Original languageEnglish
Pages (from-to)502-510
Number of pages9
JournalNeuromuscular Disorders
Volume25
Issue number6
DOIs
Publication statusPublished - 2015 Jun 1

Fingerprint

Genes
Mutation
Exome
Muscular Dystrophies
Dysferlinopathy

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Neurology
  • Clinical Neurology
  • Genetics(clinical)

Cite this

Shin, Ha Young ; Jang, Hoon ; Han, Joo Hyung ; Park, Hyung Jun ; Lee, Jung Hwan ; Kim, So Won ; Kim, Seung Min ; Park, Young Eun ; Kim, Dae Seong ; Bang, Duhee ; Lee, Min Goo ; Lee, Ji Hyun ; Choi, Youngchul. / Targeted next-generation sequencing for the genetic diagnosis of dysferlinopathy. In: Neuromuscular Disorders. 2015 ; Vol. 25, No. 6. pp. 502-510.
@article{d11fe1a4a9d54fb48bf43dc63e475eee,
title = "Targeted next-generation sequencing for the genetic diagnosis of dysferlinopathy",
abstract = "Dysferlinopathy comprises a group of autosomal recessive muscular dystrophies caused by mutations in the DYSF gene. Due to the large size of the gene and its lack of mutational hot spots, analysis of the DYSF gene is time-consuming and laborious using conventional sequencing methods. By next-generation sequencing (NGS), DYSF gene analysis has previously been validated through its incorporation in multi-gene panels or exome analyses. However, individual validation of NGS approaches for DYSF gene has not been performed. Here, we established and validated a hybridization capture-based target-enrichment followed by next-generation sequencing to detect mutations in patients with dysferlinopathy. With this approach, mean depth of coverage was approximately 450 fold and almost all (99.3{\%}) of the targeted region had sequence coverage greater than 20 fold. When this approach was tested on samples from patients with known DYSF mutations, all known mutations were correctly retrieved. Using this method on 32 consecutive patient samples with dysferlinopathy, at least two pathogenic variants were detected in 28 (87.5{\%}) samples and at least one pathogenic variant was identified in all samples. Our results suggested that the NGS-based screening method could facilitate efficient and accurate genetic diagnosis of dysferlinopathy.",
author = "Shin, {Ha Young} and Hoon Jang and Han, {Joo Hyung} and Park, {Hyung Jun} and Lee, {Jung Hwan} and Kim, {So Won} and Kim, {Seung Min} and Park, {Young Eun} and Kim, {Dae Seong} and Duhee Bang and Lee, {Min Goo} and Lee, {Ji Hyun} and Youngchul Choi",
year = "2015",
month = "6",
day = "1",
doi = "10.1016/j.nmd.2015.03.006",
language = "English",
volume = "25",
pages = "502--510",
journal = "Neuromuscular Disorders",
issn = "0960-8966",
publisher = "Elsevier Limited",
number = "6",

}

Shin, HY, Jang, H, Han, JH, Park, HJ, Lee, JH, Kim, SW, Kim, SM, Park, YE, Kim, DS, Bang, D, Lee, MG, Lee, JH & Choi, Y 2015, 'Targeted next-generation sequencing for the genetic diagnosis of dysferlinopathy', Neuromuscular Disorders, vol. 25, no. 6, pp. 502-510. https://doi.org/10.1016/j.nmd.2015.03.006

Targeted next-generation sequencing for the genetic diagnosis of dysferlinopathy. / Shin, Ha Young; Jang, Hoon; Han, Joo Hyung; Park, Hyung Jun; Lee, Jung Hwan; Kim, So Won; Kim, Seung Min; Park, Young Eun; Kim, Dae Seong; Bang, Duhee; Lee, Min Goo; Lee, Ji Hyun; Choi, Youngchul.

In: Neuromuscular Disorders, Vol. 25, No. 6, 01.06.2015, p. 502-510.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Targeted next-generation sequencing for the genetic diagnosis of dysferlinopathy

AU - Shin, Ha Young

AU - Jang, Hoon

AU - Han, Joo Hyung

AU - Park, Hyung Jun

AU - Lee, Jung Hwan

AU - Kim, So Won

AU - Kim, Seung Min

AU - Park, Young Eun

AU - Kim, Dae Seong

AU - Bang, Duhee

AU - Lee, Min Goo

AU - Lee, Ji Hyun

AU - Choi, Youngchul

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Dysferlinopathy comprises a group of autosomal recessive muscular dystrophies caused by mutations in the DYSF gene. Due to the large size of the gene and its lack of mutational hot spots, analysis of the DYSF gene is time-consuming and laborious using conventional sequencing methods. By next-generation sequencing (NGS), DYSF gene analysis has previously been validated through its incorporation in multi-gene panels or exome analyses. However, individual validation of NGS approaches for DYSF gene has not been performed. Here, we established and validated a hybridization capture-based target-enrichment followed by next-generation sequencing to detect mutations in patients with dysferlinopathy. With this approach, mean depth of coverage was approximately 450 fold and almost all (99.3%) of the targeted region had sequence coverage greater than 20 fold. When this approach was tested on samples from patients with known DYSF mutations, all known mutations were correctly retrieved. Using this method on 32 consecutive patient samples with dysferlinopathy, at least two pathogenic variants were detected in 28 (87.5%) samples and at least one pathogenic variant was identified in all samples. Our results suggested that the NGS-based screening method could facilitate efficient and accurate genetic diagnosis of dysferlinopathy.

AB - Dysferlinopathy comprises a group of autosomal recessive muscular dystrophies caused by mutations in the DYSF gene. Due to the large size of the gene and its lack of mutational hot spots, analysis of the DYSF gene is time-consuming and laborious using conventional sequencing methods. By next-generation sequencing (NGS), DYSF gene analysis has previously been validated through its incorporation in multi-gene panels or exome analyses. However, individual validation of NGS approaches for DYSF gene has not been performed. Here, we established and validated a hybridization capture-based target-enrichment followed by next-generation sequencing to detect mutations in patients with dysferlinopathy. With this approach, mean depth of coverage was approximately 450 fold and almost all (99.3%) of the targeted region had sequence coverage greater than 20 fold. When this approach was tested on samples from patients with known DYSF mutations, all known mutations were correctly retrieved. Using this method on 32 consecutive patient samples with dysferlinopathy, at least two pathogenic variants were detected in 28 (87.5%) samples and at least one pathogenic variant was identified in all samples. Our results suggested that the NGS-based screening method could facilitate efficient and accurate genetic diagnosis of dysferlinopathy.

UR - http://www.scopus.com/inward/record.url?scp=84929654766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929654766&partnerID=8YFLogxK

U2 - 10.1016/j.nmd.2015.03.006

DO - 10.1016/j.nmd.2015.03.006

M3 - Article

C2 - 25868377

AN - SCOPUS:84929654766

VL - 25

SP - 502

EP - 510

JO - Neuromuscular Disorders

JF - Neuromuscular Disorders

SN - 0960-8966

IS - 6

ER -